登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码： 002863 证券简称： 今飞凯达 公告编号： 2026-006 浙江今飞凯达轮毂股份有限公司 第五届董事会第三十一次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 浙江今飞凯达轮毂股份有限公司（以下简称"今飞凯达"或"公司"）第五届董事会第三十一次会议于2026 年1月30日在公司会议室以现场与通讯结合方式召开，本次会议的通知已于2026年1月23日以电子邮件形 式发出。本次会议由董事长葛炳灶先生召集并主持，应出席董事8名，亲自出席董事8名，其中叶龙勤先 生、王亚卡先生、胡剑锋先生、屠迪女士以通讯方式参加。公司部分高级管理人员列席了会议。本次会 议符合《中华人民共和国公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 （一）会议以5票同意、0票反对、0票弃权、3票回避的结果审议通过了《关于公司2026年度日常关联交 易预计的议案》； 公司于2026年1月30日召开第五届董事会2026年第一次独立董事专门会议，审议通过了《关于公司2026 年度日常关联 ...

Group 1 - The company, Lichung Group, announced that its subsidiary, Tianjin Lichung, has received a project confirmation notice for aluminum alloy wheels from a client [1] - The project is expected to commence mass production in July 2027 and has a lifecycle of 8 years [1] - The total sales amount projected over the project's lifecycle is approximately 820 million yuan [1]

Group 1: Company Performance - SMIC reported a revenue of 17.162 billion yuan in Q3 2025, a year-on-year increase of 9.9%, with a net profit of 1.51 billion yuan, up 43.1% year-on-year. For the first three quarters, revenue reached 49.51 billion yuan, growing 18.2%, and net profit was 3.81 billion yuan, an increase of 41.1% year-on-year, driven by increased wafer sales and product mix changes [1] - Huasheng Lithium reported a revenue of 538.5553 million yuan for the first three quarters of 2025, a year-on-year increase of 62.29%, but still incurred a net loss of 102.9745 million yuan [5] Group 2: Stock Performance and Risks - Aofeng China announced that its stock price has significantly deviated from its fundamentals, with a cumulative increase of 230.84% over 13 trading days, leading to potential risks for investors if the stock continues to rise abnormally [2] - Renmin Tongtai's stock experienced a cumulative increase of 46.43% over four consecutive trading days, with the company warning of potential rapid declines due to market sentiment and irrational speculation [4] Group 3: Mergers and Acquisitions - Guotai Group announced the acquisition of 100% equity in Beikuan Baomao for 110 million yuan through a public bidding process [3] Group 4: New Projects and Contracts - Lichong Group's subsidiaries received project confirmations for aluminum alloy wheels, with expected total sales of approximately 1.135 billion yuan over the project lifecycles [15] - Anhui Construction's subsidiary won a bid for a project worth 1.753 billion yuan, including two major contracts with a total construction cost of approximately 1.215 billion yuan and 538 million yuan respectively [16] Group 5: Clinical Trials and Innovations - Haishi Science received approval for clinical trials of HSK39297 tablets for age-related macular degeneration, indicating strong development potential and a favorable benefit/risk ratio [6]